Trial reportAnnals of surgical oncology2026
Laparoscopic Versus Robotic Adrenalectomy: A Randomized Clinical Trial.
Trial report in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Ergonomics in Knee Arthroscopy: A Scoping Review.Arthroscopy, sports medicine, and rehabilitation · 2026Review
- Review
- Transition to robotic adrenalectomy: a surgeon-specific learning curve evaluation.Journal of robotic surgery · 2026Article
- ASO Author Reflections: Laparoscopic versus Robotic Adrenalectomy in the Current Era.Annals of surgical oncology · 2026Article
- Robotic versus laparoscopic adrenalectomy: five-year comparative outcomes from a high-volume tertiary endocrine surgery center.Journal of robotic surgery · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to compare perioperative outcomes between laparoscopic and robotic transabdominal lateral adrenalectomies.
backgroundDespite growing interest in robotic adrenalectomy (RA), its benefits compared with those for laparoscopic adrenalectomy (LA) need to be identified. Two previously published randomized studies used out-of-date technologies and included only pheochromocytoma patients, respectively.
methodsA prospective randomized clinical trial was conducted by a single surgeon between May 2024 and February 2025. Patients with adrenal tumors eligible for minimally invasive lateral transabdominal adrenalectomy were randomized to LA or RA. The trial was powered to detect a 30-min difference in operative time. The secondary outcomes were perioperative outcomes, cost, and ergonomics, measured by the NASA Task Load Index (NASA-TLX) and the Rapid Upper Limb Assessment (RULA).
resultsIn the study, 27 patients were randomized to each group. The groups were similar in demographics, clinical characteristics, and operative indications. The operative times and secondary outcomes were similar between the groups except that the RA group had a lower median operating surgeon NASA-TLX score (16 vs 48; P ≤ 0.001) and a lower overall RULA score (14 vs 17; P = 0.001) than the LA group. Operation room, hospital, and total costs were similar between the groups. Although all the procedures were completed as planned in the RA group, the LA group had four conversions from the original minimally invasive plan (conversion to open, hand-assisted procedure, and partial adrenalectomy and abortion of the procedure in one patient each).
conclusionsPerioperative outcomes, including cost, were similar between LA and RA, with better ergonomics and fewer conversions from the original minimally invasive surgical plan in the RA group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.